Clinical Trial

Plasma Exchange in Children With Severe Sepsis and Septic Shock

Study acronym: PE/Sepsis
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study will be to to evaluate whether therapeutic plasma exchange (TPE) reduces mortality in critically ill children with severe sepsis or septic shock compared to the standard care of sepsis alone. The study population will be divided into two groups, the first group will receive standard sepsis management plus therapeutic plasma exchange and the second one will receive the standard sepsis management alone . Then we will assess the effect of TPE on : Severity of organ dysfunction (pSOFA score) , duration of vasopressor support , length of PICU stay, time to hemodynamic stabilization , and on inflammatory and coagulation biomarkers
Trial Details
NCT Number NCT07706413
Lead Sponsor Menoufia University
Conditions Severe Sepsis
Enrollment 22 participants
Start Date 2026-08-01
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-15